61 related articles for article (PubMed ID: 21484077)
21. The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.
Maleki Dana P; Sadoughi F; Asemi Z; Yousefi B
Cell Mol Biol Lett; 2022 Jan; 27(1):1. PubMed ID: 34979906
[TBL] [Abstract][Full Text] [Related]
22. Curcumin-Induced DNA Demethylation in Human Gastric Cancer Cells Is Mediated by the DNA-Damage Response Pathway.
Tong R; Wu X; Liu Y; Liu Y; Zhou J; Jiang X; Zhang L; He X; Ma L
Oxid Med Cell Longev; 2020; 2020():2543504. PubMed ID: 32617134
[TBL] [Abstract][Full Text] [Related]
23. Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and -independent apoptosis via Smad or Akt signaling pathways in HOS cells.
Huang C; Lu HF; Chen YH; Chen JC; Chou WH; Huang HC
BMC Complement Med Ther; 2020 Mar; 20(1):68. PubMed ID: 32126993
[TBL] [Abstract][Full Text] [Related]
24. Preparation of poly(lactide-co-glycolide) microspheres and evaluation of pharmacokinetics and tissue distribution of BDMC-PLGA-MS in rats.
Li G; Yao L; Li J; Qin X; Qiu Z; Chen W
Asian J Pharm Sci; 2018 Jan; 13(1):82-90. PubMed ID: 32104381
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer.
Wan Mohd Tajuddin WNB; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817718
[TBL] [Abstract][Full Text] [Related]
26. Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects.
Hassan FU; Rehman MS; Khan MS; Ali MA; Javed A; Nawaz A; Yang C
Front Genet; 2019; 10():514. PubMed ID: 31214247
[TBL] [Abstract][Full Text] [Related]
27. WIF-1 gene inhibition and Wnt signal transduction pathway activation in NSCLC tumorigenesis.
Tang Q; Zhao H; Yang B; Li L; Shi Q; Jiang C; Liu H
Oncol Lett; 2017 Mar; 13(3):1183-1188. PubMed ID: 28454231
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review.
Guo H; Zhou S; Tan L; Wu X; Wu Z; Ran R
Oncotarget; 2017 Jan; 8(2):2550-2557. PubMed ID: 27911280
[TBL] [Abstract][Full Text] [Related]
29. "Curcumin, the King of Spices": Epigenetic Regulatory Mechanisms in the Prevention of Cancer, Neurological, and Inflammatory Diseases.
Boyanapalli SS; Kong AT
Curr Pharmacol Rep; 2015 Apr; 1(2):129-139. PubMed ID: 26457241
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic impact of curcumin on stroke prevention.
Kalani A; Kamat PK; Kalani K; Tyagi N
Metab Brain Dis; 2015 Apr; 30(2):427-35. PubMed ID: 24788895
[TBL] [Abstract][Full Text] [Related]
31. Curcumin inhibits the AKT/NF-κB signaling via CpG demethylation of the promoter and restoration of NEP in the N2a cell line.
Deng Y; Lu X; Wang L; Li T; Ding Y; Cao H; Zhang Y; Guo X; Yu G
AAPS J; 2014 Jul; 16(4):649-57. PubMed ID: 24756894
[TBL] [Abstract][Full Text] [Related]
32. Bisdemethoxycurcumin inhibits PDGF-induced vascular smooth muscle cell motility and proliferation.
Hua Y; Dolence J; Ramanan S; Ren J; Nair S
Mol Nutr Food Res; 2013 Sep; 57(9):1611-8. PubMed ID: 23554078
[TBL] [Abstract][Full Text] [Related]
33. A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics.
Su ZY; Shu L; Khor TO; Lee JH; Fuentes F; Kong AN
Top Curr Chem; 2013; 329():133-62. PubMed ID: 22836898
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.
Stefanska B; Karlic H; Varga F; Fabianowska-Majewska K; Haslberger A
Br J Pharmacol; 2012 Sep; 167(2):279-97. PubMed ID: 22536923
[TBL] [Abstract][Full Text] [Related]
35. Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line.
Parashar G; Parashar NC; Capalash N
Mol Cell Biochem; 2012 Jun; 365(1-2):29-35. PubMed ID: 22297615
[TBL] [Abstract][Full Text] [Related]
36. Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines.
Liu YL; Yang HP; Gong L; Tang CL; Wang HJ
Mol Med Rep; 2011; 4(4):675-9. PubMed ID: 21484077
[TBL] [Abstract][Full Text] [Related]
37. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer.
Liu YL; Yang HP; Zhou XD; Gong L; Tang CL; Wang HJ
Curr Cancer Drug Targets; 2011 Nov; 11(9):1098-110. PubMed ID: 21933103
[TBL] [Abstract][Full Text] [Related]
38. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
[TBL] [Abstract][Full Text] [Related]
39. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
Tan M; Wu J; Cai Y
Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.
Zheng Y; Li X; Jiang Y; Xu Y; Song B; Zhou Q; Liang X; Yang X
Medicine (Baltimore); 2016 Dec; 95(49):e5433. PubMed ID: 27930522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
